Cargando…

Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer is a lethal disease due to its late phase discovery. Any steps towards improving early diagnostics will dramatically increase survival rates. To identify new ovarian cancer biomarker panels, we need to focus on early-stage disease and all histologic subtypes. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liljedahl, Leena, Malmström, Johan, Kristjansdottir, Björg, Waldemarson, Sofia, Sundfeldt, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616310/ https://www.ncbi.nlm.nih.gov/pubmed/34830868 http://dx.doi.org/10.3390/cancers13225713

Ejemplares similares

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass
por: Partheen, Karolina, et al.
Publicado: (2011)

Early inflammatory response in epithelial ovarian tumor cyst fluids
por: Kristjánsdóttir, Björg, et al.
Publicado: (2014)

Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ
por: Kristjansdottir, Björg, et al.
Publicado: (2013)

Automated Selected Reaction Monitoring Software for Accurate Label-Free Protein Quantification
por: Teleman, Johan, et al.
Publicado: (2012)

Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers
por: Kristjansdottir, Björg, et al.
Publicado: (2012)

Increased Diagnostic Accuracy of Adnexal Tumors with A Combination of Established Algorithms and Biomarkers
por: Lycke, Maria, et al.
Publicado: (2020)

Analysis of blood group antigens on MUC5AC in mucinous ovarian cancer tissues using in situ proximity ligation assay
por: Mateoiu, Constantina, et al.
Publicado: (2021)

Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer
por: Jain, Shruti, et al.
Publicado: (2022)

Antibody orientation at bacterial surfaces is related to invasive infection
por: Nordenfelt, Pontus, et al.
Publicado: (2012)

Ovarian epithelial cancer: a role for PGE(2)-synthesis and signalling in malignant transformation and progression
por: Rask, Katarina, et al.
Publicado: (2006)

Evaluation of Sialyl-Lactotetra as a Marker for Epithelial Ovarian Tumors
por: Barone, Angela, et al.
Publicado: (2020)

Diagnostic potential of tumor DNA from ovarian cyst fluid
por: Wang, Yuxuan, et al.
Publicado: (2016)

Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes
por: Gong, Ting-Ting, et al.
Publicado: (2023)

Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b
por: Levan, Kristina, et al.
Publicado: (2017)

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
por: Enroth, Stefan, et al.
Publicado: (2019)

Epithelial Ovarian Cancer and the Occurrence of Skin Cancer in The Netherlands: Histological Type Connotations
por: van Niekerk, Catharina C., et al.
Publicado: (2011)

Histology-Verified Intracranial Artery Calcification and Its Clinical Relevance With Cerebrovascular Disease
por: Du, Heng, et al.
Publicado: (2022)

Sulfation of O-glycans on Mucin-type Proteins From Serous Ovarian Epithelial Tumors
por: Thomsson, Kristina A., et al.
Publicado: (2021)

Proteome-wide selected reaction monitoring assays for the human pathogen Streptococcus pyogenes
por: Karlsson, Christofer, et al.
Publicado: (2012)

Novel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules
por: Teoh, Eugene J., et al.
Publicado: (2015)

Grading Breast Cancer Tissues Using Molecular Portraits
por: Olsson, Niclas, et al.
Publicado: (2013)

Predicted novel hypertrehalosaemic peptides of cockroaches are verified by mass spectrometry
por: Marco, Heather G., et al.
Publicado: (2023)

Verifiable composition of signature and encryption: a comprehensive study of the design paradigms
por: El Aimani, Laila
Publicado: (2017)

New DoS Defense Method Based on Strong Designated Verifier Signatures
por: de Almeida, Marcone Pereira, et al.
Publicado: (2018)

TGF-β isoforms induce EMT independent migration of ovarian cancer cells
por: Gao, Jingfang, et al.
Publicado: (2014)

The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors
por: Vitiazeva, Varvara, et al.
Publicado: (2015)

The association of left ventricular histologically verified myocardial fibrosis with pulmonary hypertension in severe aortic stenosis
por: Gumauskiene, Birute, et al.
Publicado: (2021)

Keypunching and verifying
por: Farina, Mario V.
Publicado: (1973)

To trust? Or to verify?
por: Harendza, Sigrid
Publicado: (2018)

Verifiable biology
por: Konur, Savas, et al.
Publicado: (2023)

A Verifiable Arbitrated Quantum Signature Scheme Based on Controlled Quantum Teleportation
por: Lu, Dianjun, et al.
Publicado: (2022)

Effects of insulin and the glucagon‐like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice
por: Liljedahl, Leena, et al.
Publicado: (2017)

Verifiability on the run: an experimental study on the verifiability approach to malingered symptoms
por: Boskovic, Irena, et al.
Publicado: (2018)

Dietary fat intake and risk of epithelial ovarian cancer by tumour histology
por: Merritt, M A, et al.
Publicado: (2014)

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2018)

Computed Tomographic Radiomics in Differentiating Histologic Subtypes of Epithelial Ovarian Carcinoma
por: Wang, Mandi, et al.
Publicado: (2022)

The impact of the glucagon‐like peptide 1 receptor agonist liraglutide on the streptozotocin‐induced diabetic mouse kidney proteome
por: Liljedahl, Leena, et al.
Publicado: (2019)

Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers
por: Mukherjee, Shuvolina, et al.
Publicado: (2021)

Verifying Diagnosis of Refractory Celiac Disease With Urine Gluten Immunogenic Peptides as Biomarker
por: Moreno, María de Lourdes, et al.
Publicado: (2021)

Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer
por: Wang, Chen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_evektm7lchu3q47sqlqlj2ikhp